(Q37900923)

25 August 2017

1 reference

title

Biology of vascular endothelial growth factor and its receptors in head and neck cancer: beyond angiogenesis (English)

1 reference

25 August 2017

0 references

1 reference

1 reference

1 reference

head and neck carcinoma

1 reference

inferred from title

author name string

Apostolos Christopoulos

1

1 reference

25 August 2017

Sun M Ahn

2

1 reference

25 August 2017

Jonah D Klein

3

1 reference

25 August 2017

Seungwon Kim

4

1 reference

25 August 2017

language of work or name

1 reference

16 December 2010

1 reference

25 August 2017

1 reference

25 August 2017

volume

33

1 reference

25 August 2017

issue

8

1 reference

25 August 2017

page(s)

1220-1229

1 reference

Targeting receptor tyrosine kinases and their signal transduction routes in head and neck cancer

25 August 2017

cites work

1 reference

Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis

21 January 2018

1 reference

Vascular endothelial growth factor receptor-2: structure, function, intracellular signalling and therapeutic inhibition

21 January 2018

1 reference

The biology of VEGF and its receptors

21 January 2018

1 reference

Tumor angiogenesis: therapeutic implications

21 January 2018

1 reference

Current concepts of tumor-induced angiogenesis

21 January 2018

1 reference

The implications of angiogenesis for the biology and therapy of cancer metastasis

21 January 2018

1 reference

Head and neck squamous cell carcinoma lines produce biologically active angiogenic factors

21 January 2018

1 reference

Microvessel density in head and neck squamous cell carcinoma primary tumors and its correlation with clinical staging parameters.

21 January 2018

1 reference

Vascular endothelial growth factor as a target for anticancer therapy

21 January 2018

1 reference

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

Oxygen sensors and angiogenesis

21 January 2018

1 reference

The role of neuropilins in cancer

21 January 2018

1 reference

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

Two steps forward in the treatment of colorectal cancer

21 January 2018

1 reference

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

21 January 2018

1 reference

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

21 January 2018

1 reference

Combined vascular endothelial growth factor receptor and epidermal growth factor receptor (EGFR) blockade inhibits tumor growth in xenograft models of EGFR inhibitor resistance

21 January 2018

1 reference

VEGF signaling inhibitors: more pro-apoptotic than anti-angiogenic

21 January 2018

1 reference

Sorafenib in advanced clear-cell renal-cell carcinoma

21 January 2018

1 reference

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer

21 January 2018

1 reference

Phase I/II trial evaluating the anti-vascular endothelial growth factor monoclonal antibody bevacizumab in combination with the HER-1/epidermal growth factor receptor tyrosine kinase inhibitor erlotinib for patients with recurrent non-small-cell lun

21 January 2018

1 reference

Phase II trial of bevacizumab plus gemcitabine in patients with advanced pancreatic cancer

21 January 2018

1 reference

Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis

21 January 2018

1 reference

Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis

21 January 2018

1 reference

Inhibition of multiple vascular endothelial growth factor receptors (VEGFR) blocks lymph node metastases but inhibition of VEGFR-2 is sufficient to sensitize tumor cells to platinum-based chemotherapeutics

21 January 2018

1 reference

Vascular endothelial growth factor trap blocks tumor growth, metastasis formation, and vascular leakage in an orthotopic murine renal cell cancer model

21 January 2018

1 reference

Synergistic antitumor effects of combined epidermal growth factor receptor and vascular endothelial growth factor receptor-2 targeted therapy

21 January 2018

1 reference

Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study

21 January 2018

1 reference

Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer

21 January 2018

1 reference

Tumor cell and endothelial cell therapy of oral cancer by dual tyrosine kinase receptor blockade

21 January 2018

1 reference

Erlotinib and bevacizumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck: a phase I/II study

21 January 2018

1 reference

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

21 January 2018

1 reference

Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinoma.

21 January 2018

1 reference

Vascular endothelial growth factor acts in an autocrine manner in rhabdomyosarcoma cell lines and can be inhibited with all-trans-retinoic acid

21 January 2018

1 reference

Both antiangiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584.

21 January 2018

1 reference

Vascular endothelial growth factor receptor-1 promotes migration and invasion in pancreatic carcinoma cell lines

21 January 2018

1 reference

Vascular endothelial growth factor receptor-1 activation mediates epithelial to mesenchymal transition in human pancreatic carcinoma cells

21 January 2018

1 reference

Modulation of cellular invasion by VEGF-C expression in squamous cell carcinoma of the head and neck

21 January 2018

1 reference

Human head and neck squamous cell carcinoma cells are both targets and effectors for the angiogenic cytokine, VEGF.

21 January 2018

1 reference

Migration-promoting role of VEGF-C and VEGF-C binding receptors in human breast cancer cells.

21 January 2018

1 reference

Autocrine vascular endothelial growth factor signalling in breast cancer. Evidence from cell lines and primary breast cancer cultures in vitro.

21 January 2018

1 reference

Differential involvement of vascular endothelial growth factor in the survival of hypoxic colon cancer cells

21 January 2018

1 reference

Short interfering RNA-mediated gene silencing of vascular endothelial growth factor: effects on cellular proliferation in colon cancer cells

21 January 2018

1 reference

Flt-1-Dependent Survival Characterizes the Epithelial-Mesenchymal Transition of Colonic Organoids

21 January 2018

1 reference

Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver

21 January 2018

1 reference

Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect

21 January 2018

1 reference

A hypoxia-driven vascular endothelial growth factor/Flt1 autocrine loop interacts with hypoxia-inducible factor-1alpha through mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 pathway in neuroblastoma

21 January 2018

1 reference

Expression of vascular endothelial growth factor (VEGF) and its receptors in thyroid carcinomas of follicular origin: a potential autocrine loop.

21 January 2018

1 reference

Antiangiogenic and antitumor effects of bevacizumab in patients with inflammatory and locally advanced breast cancer

21 January 2018

1 reference

VEGF is up-regulated by hypoxic stimulation and related to tumour angiogenesis and severity of disease in oral squamous cell carcinoma: in vitro and in vivo studies

21 January 2018

1 reference

Potential autocrine function of vascular endothelial growth factor in head and neck cancer via vascular endothelial growth factor receptor-2.

21 January 2018

1 reference

Epidemiology of head and neck cancer in the United States

21 January 2018

1 reference

7 January 2021

Recent advances in head and neck cancer

1 reference

7 January 2021

Vascular endothelial growth factor (VEGF) and its receptors

1 reference

7 January 2021

How tumors become angiogenic

1 reference

7 January 2021

Serum levels of vascular endothelial growth factor in patients with head and neck cancer

1 reference

7 January 2021

Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma

1 reference

7 January 2021

Immunohistochemical study of tumour angiogenesis in oral squamous cell carcinoma

1 reference

7 January 2021

Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma

1 reference

7 January 2021

Strong immunohistochemical expression of vascular endothelial growth factor predicts overall survival in head and neck squamous cell carcinoma

1 reference

7 January 2021

Randomized phase II trial of cetuximab, bevacizumab, and irinotecan compared with cetuximab and bevacizumab alone in irinotecan-refractory colorectal cancer: the BOND-2 study

1 reference

7 January 2021

A Phase II study of SU5416 in patients with advanced or recurrent head and neck cancers

1 reference

7 January 2021

Expression and function of vascular endothelial growth factor receptor-1 on human colorectal cancer cells

1 reference

7 January 2021

Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Expression in Squamous Cell Carcinomas of the Head and Neck

1 reference

7 January 2021

Prognostic significance of vascular endothelial growth factor immunohistochemical expression in head and neck squamous cell carcinoma: a meta-analysis

1 reference

7 January 2021

A peptide corresponding to the neuropilin-1-binding site on VEGF165 induces apoptosis of neuropilin-1-expressing breast tumour cells

1 reference

7 January 2021

Vascular endothelial growth factor receptor-1 mediates migration of human colorectal carcinoma cells by activation of Src family kinases

1 reference

7 January 2021

Tumor hypoxia and systemic levels of vascular endothelial growth factor (VEGF) in head and neck cancers

1 reference

7 January 2021

Expression of vascular endothelial growth factor receptors on tumor cells in head and neck squamous cell carcinoma

1 reference

7 January 2021

Identifiers

DOI

10.1002/HED.21588

1 reference

25 August 2017

1 reference